Sign in with your email address username.


[Comment] Pulmonary pressure, telemedicine, and heart failure therapy

Heart failure is a leading cause of hospital admissions in patients with cardiac diseases and poses a huge burden for patients and societies. In recent years, major advances have been made with the introduction of new drugs and novel interventional approaches such as cardiac resynchronisation therapy. However, there is a need for further improvement, especially considering the projection for increases in heart failure prevalence caused by ageing of the population. Longer survival of patients with cardiac diseases, an effect of modern life-extending treatments, such as primary angioplasty for myocardial infarction and implantable defibrillators for prevention of sudden cardiac death, also contributes to the need for more effective therapies for heart failure.